Skip to main content

Pharma News

pharma courses

 

gpat

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Heart healthy behaviors may help reverse rapid cell aging

    The benefit of better heart health may be associated with the positive impact of heart healthy lifestyle factors on biological aging (the age of the body and its cells), according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

  • New study discovers tiny target on RNA to short-circuit inflammation
    This peptide originates from within a long non-coding RNA called LOUP. According to the researchers, the human genome encodes over 20,000 lncRNAs, making it the largest group of genes produced from the genome. But despite this abundance, scientists know little about why lncRNAs exist or what they do
  • Pharma Quality Excellence Awards 2024 : A Night of Elegance and Triumph

    In the glistening ambiance of success and camaraderie, the stage was set for an evening of unparalleled splendor and distinction as the maiden edition of Pharma Quality Excellence Awards 2024 unfolded in all its grandeur. 

  • 4th Annual Pharma GMP & Quality Management 2024

    A Comprehensive Post-Show Review

  • Scripps Research scientists uncover new molecular drivers of Alzheimer’s

    According to the US Centers for Disease Control and Prevention, at least 5.8 million Americans are currently living with Alzheimer’s disease, which is the most common form of dementia. There is no cure for Alzheimer’s, in part because scientists do not yet have a full understanding of what causes the disease. But a new study from Scripps Research is shedding light on the molecular drivers that could contribute to Alzheimer’s progression.

  • New advances in cancer viral immunotherapy

    Vaccinia viruses are therapeutic tools with different biomedical applications depending on the susceptibility characteristics. For example, the strain called MVA (modified vaccinia Ankara), which is unable to replicate in mammalian cells, triggers a potent immune system response and is used to develop vaccines against COVID-19 or AIDS. In contrast, other strains such as Western Reserve (WR) or Copenhagen (Cop), which replicate efficiently in tumour cells, are used to develop cancer treatments.

  • Nitrosamine Advance Workshop 2024 A Comprehensive Post-Show Review

    Nitrosamine Advance Workshop 2024, conducted on May 9th and 10th at Radisson Blu Mumbai International Airport, has emerged as a watershed moment in the pharma industry boosting collaboration and innovation in the detection of the Nitrosamine landscape.

  • Advance DoE Workshop 2024 : A Testament to the Power of Collaboration, education, and innovation

    An exclusive Advance DoE Workshop 2024 hosted by Eminence Business Media, concluded with resounding success, inspiring participants with valuable insights to enhance their experimental design and optimization skills.

  • A Trial HIV Vaccine Triggered Elusive and Essential Antibodies in Humans

    An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.

    The finding, reported May 17 in the journal Cell, not only provides proof that a vaccine can elicit these antibodies to fight diverse strains of HIV, but that it can also initiate the process within weeks, setting in motion an essential immune response.

  • Study Paves the Way for an Active Agent Against Hepatitis E
    At present, there is no specific active substance against hepatitis E. As the disease kills 70,000 people every year, researchers are actively searching for one. The team from the Department of Molecular and Medical Virology at Ruhr University Bochum, Germany, may have found what they’re looking for.
Subscribe to Pharma News